Clinical Trial Update: A Study of SN2001 Dose, Safety & Immunogenicity in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 study of SN2001 to assess dose, safety, and immunogenicity in healthy adults. Chronic hepatitis B infection is listed as the condition, and the trial is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• SN2001

Snippet

Sponsor: Chimivac INC | Conditions: Chronic Hepatitis B Infection | Phase 1 | Status: RECRUITING